Why is New York suing Capital One?
How will new Social Security rules affect retirees?
What impact will ESPN’s new streaming app have?
Why is GSK investing heavily in liver disease drugs?
How did Trump’s Middle East trip boost AI deals?
What risks do proposed Medicaid cuts pose?
How will Canada’s delayed budget affect the economy?
Why did Amazon cut jobs in its devices unit?
What caused Foot Locker’s stock surge amid buyout talks?
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
benzinga.com/general/biotech/25/05/45418687/fda-fast-tracks-abbvies-new-lung-cancer-therapy-emrelis-for-tough-lung-cancer-cases
The U.S. Food and Drug Administration (FDA) granted accelerated approval to AbbVie Inc.’s (NYSE:ABBV) Emrelis (telisotuzumab vedotin-tllv) for adult patients with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression (OE)…
This story appeared on benzinga.com, 2025-05-14 19:25:05.